Anthony M. Jevnikar

10.4k total citations · 1 hit paper
209 papers, 8.2k citations indexed

About

Anthony M. Jevnikar is a scholar working on Immunology, Surgery and Molecular Biology. According to data from OpenAlex, Anthony M. Jevnikar has authored 209 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Immunology, 66 papers in Surgery and 56 papers in Molecular Biology. Recurrent topics in Anthony M. Jevnikar's work include Renal Transplantation Outcomes and Treatments (44 papers), Immune Cell Function and Interaction (41 papers) and T-cell and B-cell Immunology (35 papers). Anthony M. Jevnikar is often cited by papers focused on Renal Transplantation Outcomes and Treatments (44 papers), Immune Cell Function and Interaction (41 papers) and T-cell and B-cell Immunology (35 papers). Anthony M. Jevnikar collaborates with scholars based in Canada, United States and China. Anthony M. Jevnikar's co-authors include Bertha García, Robert Zhong, Zhu‐Xu Zhang, Ewa Cairns, Jonathan A. Hill, David Bell, Shengwu Ma, Laurie H. Glimcher, Wei‐Ping Min and Rudolf P. Wüthrich and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Anthony M. Jevnikar

203 papers receiving 8.0k citations

Hit Papers

Cutting Edge: The Conversion of Arginine to Citrulline Al... 2003 2026 2010 2018 2003 100 200 300 400 500

Peers

Anthony M. Jevnikar
Elsie M. Eugui United States
Curtis B. Wilson United States
Joshua M. Thurman United States
Robert L. Fairchild United States
Xin Xiao Zheng United States
Anil Chandraker United States
Hein W. Verspaget Netherlands
Kelly L. Hudkins United States
Anthony M. Jevnikar
Citations per year, relative to Anthony M. Jevnikar Anthony M. Jevnikar (= 1×) peers Antonino Nicoletti

Countries citing papers authored by Anthony M. Jevnikar

Since Specialization
Citations

This map shows the geographic impact of Anthony M. Jevnikar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony M. Jevnikar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony M. Jevnikar more than expected).

Fields of papers citing papers by Anthony M. Jevnikar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony M. Jevnikar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony M. Jevnikar. The network helps show where Anthony M. Jevnikar may publish in the future.

Co-authorship network of co-authors of Anthony M. Jevnikar

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony M. Jevnikar. A scholar is included among the top collaborators of Anthony M. Jevnikar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony M. Jevnikar. Anthony M. Jevnikar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gunaratnam, Lakshman, Anthony M. Jevnikar, Patrick Luke, et al.. (2023). The effect of late‐onset CMV infection on the outcome of renal allograft considering initial graft function. Transplant Infectious Disease. 25(4). e14081–e14081.
2.
Ma, Shengwu, et al.. (2017). Emerging technologies to achieve oral delivery of GLP-1 and GLP-1 analogs for treatment of type 2 diabetes mellitus (T2DM). SHILAP Revista de lepidopterología. 1(1). 1–10. 9 indexed citations
3.
Filler, Guido, Alexander A. Vinks, Shih‐Han S. Huang, Anthony M. Jevnikar, & Norman Muirhead. (2013). Similar MPA Exposure on Modified Release and Regular Tacrolimus. Therapeutic Drug Monitoring. 36(3). 353–357. 7 indexed citations
4.
Singh, Bhagirath, et al.. (2011). Immunomodulation and Regeneration of Islet Beta Cells by Cytokines in Autoimmune Type 1 Diabetes. Journal of Interferon & Cytokine Research. 31(10). 711–719. 30 indexed citations
5.
Wang, Xiaofeng, et al.. (2010). Plant-derived recombinant human serum transferrin demonstrates multiple functions. Plant Biotechnology Journal. 8(4). 489–505. 19 indexed citations
6.
Kohalmi, Susanne E., et al.. (2009). A Proficient Approach to the Production of Therapeutic Glucagon-LikePeptide-1 (GLP-1) in Transgenic Plants. The Open Biotechnology Journal. 3(1). 57–66. 14 indexed citations
7.
Wang, Hao, Wei Ge, Jacqueline Arp, et al.. (2009). Free Bone Graft Attenuates Acute Rejection and in Combination with Cyclosporin A Leads to Indefinite Cardiac Allograft Survival. The Journal of Immunology. 182(10). 5970–5981. 6 indexed citations
8.
Zheng, Xiufen, Xusheng Zhang, Biao Feng, et al.. (2008). Gene Silencing of Complement C5a Receptor Using siRNA for Preventing Ischemia/Reperfusion Injury. American Journal Of Pathology. 173(4). 973–980. 83 indexed citations
9.
Zhang, Zhu‐Xu, Shuang Wang, Xuyan Huang, et al.. (2008). NK Cells Induce Apoptosis in Tubular Epithelial Cells and Contribute to Renal Ischemia-Reperfusion Injury. The Journal of Immunology. 181(11). 7489–7498. 128 indexed citations
10.
Conley, Andrew, Kanishka Mohib, Anthony M. Jevnikar, & Jim Brandle. (2008). Plant recombinant erythropoietin attenuates inflammatory kidney cell injury. Plant Biotechnology Journal. 7(2). 183–199. 37 indexed citations
11.
Zheng, Xiufen, Xusheng Zhang, Hongtao Sun, et al.. (2006). Protection of Renal Ischemia Injury using Combination Gene Silencing of Complement 3 and Caspase 3 Genes. Transplantation. 82(12). 1781–1786. 77 indexed citations
12.
Şener, Alp, Andrew A. House, Anthony M. Jevnikar, et al.. (2006). Intravenous Immunoglobulin as a Treatment for BK Virus Associated Nephropathy. Transplantation. 81(1). 117–120. 142 indexed citations
13.
Ma, Shengwu, Yan Huang, Ziqin Yin, et al.. (2005). Production of biologically active human interleukin‐4 in transgenic tobacco and potato. Plant Biotechnology Journal. 3(3). 309–318. 37 indexed citations
14.
Ma, Shengwu, Yan Huang, Ziqin Yin, et al.. (2004). Induction of oral tolerance to prevent diabetes with transgenic plants requires glutamic acid decarboxylase (GAD) and IL-4. Proceedings of the National Academy of Sciences. 101(15). 5680–5685. 65 indexed citations
15.
Zhou, Dejun, Catherine O′Brien, Bertha García, et al.. (2003). LF 15–0195, a novel immunosuppressive agent prevents rejection and induces operational tolerance in a mouse cardiac allograft model. Transplantation. 76(4). 644–650. 14 indexed citations
16.
Hill, Jonathan A., Scott Southwood, Alessandro Sette, et al.. (2003). Cutting Edge: The Conversion of Arginine to Citrulline Allows for a High-Affinity Peptide Interaction with the Rheumatoid Arthritis-Associated HLA-DRB1*0401 MHC Class II Molecule. The Journal of Immunology. 171(2). 538–541. 541 indexed citations breakdown →
17.
Min, Wei‐Ping, Dejun Zhou, Thomas E. Ichim, et al.. (2003). Inhibitory Feedback Loop Between Tolerogenic Dendritic Cells and Regulatory T Cells in Transplant Tolerance. The Journal of Immunology. 170(3). 1304–1312. 211 indexed citations
18.
Chiu, Priscilla, Anthony M. Jevnikar, & Jayne S. Danska. (2001). Genetic Control of T and B Lymphocyte Activation in Nonobese Diabetic Mice. The Journal of Immunology. 167(12). 7169–7179. 12 indexed citations
19.
Noorchashm, Hooman, Daniel J. Moore, Negin Noorchashm, et al.. (2000). Impaired CD4 T Cell Activation Due to Reliance Upon B Cell-Mediated Costimulation in Nonobese Diabetic (NOD) Mice. The Journal of Immunology. 165(8). 4685–4696. 58 indexed citations
20.
Lazarovits, Andrew I., Lydia Visser, Toni Zhong, et al.. (1999). Mechanisms of induction of renal allograft tolerance in CD45RB-treated mice. Kidney International. 55(4). 1303–1310. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026